Beverly Hills Cancer Center

What Beverly Hills Cancer Center does

Beverly Hills Cancer Center is a privately held, academic community-based cancer treatment center operating as Beverly Hills Oncology Medical Group, Inc. from a single facility at 8900 Wilshire Blvd in Beverly Hills, California. The center delivers multidisciplinary cancer care across all major solid and hematologic tumor types, combining radiation oncology, medical oncology, immunotherapy, hematology, diagnostic imaging, and clinical trial access under one roof, supplemented by in-house laboratory, in-house pharmacy, integrative care services, and concierge offerings.

The technology stack centers on radiation oncology assets: the RefleXion X1 platform with SCINTIX biology-guided radiotherapy (the first freestanding installation globally, announced February 2025), Cyberknife robotic radiosurgery, IMRT/IGRT/SBRT capabilities, and HDR brachytherapy, paired with an ACR-accredited imaging suite covering GE 1.5T MRI, multi-slice CT, PET/CT, ultrasound, and nuclear medicine. On the medical-oncology side, the center offers chemotherapy in private infusion rooms, genetic and total genome sequencing, liquid biopsy, and multiomic biosimulation; on the research side, it runs Deep Lens' VIPER AI-driven clinical trial matching that integrates EMR with Foundation Medicine, Caris Life Sciences, Tempus, and Guardant Health molecular feeds.

Revenue is generated primarily on a fee-for-service basis from treatment, diagnostic imaging, executive health screening packages (Premiere, Executive, Total Health), and clinical trial participation. The center accepts major PPO plans (Aetna, Blue Cross, Blue Shield, Cigna, HealthNet, Humana, United Healthcare), Medicare, Medi-Cal, and HMO plans with referral, and supplements this with a cash-pay concierge tier and full-service international patient coordination. Distribution runs through direct patient intake (phone, online booking, same-day appointments), a physician referral network, insurance network participation, and concierge international patient services spanning visa assistance, interpreters, and travel logistics.

Name

Beverly Hills Cancer Center

Legal name

Beverly Hills Oncology Medical Group, Inc.

Website

https://bhcancercenter.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

101–250 employees

Short description

Beverly Hills Cancer Center is a private, multidisciplinary cancer treatment center in Beverly Hills, CA offering radiation oncology, medical oncology, advanced imaging, clinical trials, and concierge services to domestic and international cancer patients.

Ownership category

akta.pro rank

Product category

Cancer Treatment Services

NAICS

Offices of Physicians (62111), Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)

Keywords

• Radiation oncology services
• Medical oncology treatments
• Cancer diagnostic imaging
• Immunotherapy and precision oncology
• Oncology clinical trials

Headquarters

HQ city

Beverly Hills

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Cancer Treatment Services: Fee-for-service medical care including radiation oncology, medical oncology, chemotherapy, immunotherapy, and surgical oncology. Treatment costs vary by cancer type, stage, and treatment regimen. The center emphasizes competitive pricing lower than hospitals while providing higher level of efficient care.
2. Diagnostic Imaging Services: Comprehensive imaging services including MRI, CT, PET/CT, bone scans, ultrasound, and nuclear medicine. ACR accredited facility providing same-day results.
3. Health Screening Programs: Executive health screenings and cancer prevention programs with customized packages (Premiere, Executive, Total Health) offering various levels of diagnostic testing.
4. Concierge Medical Services: Premium personalized care services including around-the-clock physician access, private chemotherapy rooms, home/hotel visits, extended appointments, and customized care coordination.
5. Clinical Trial Participation: Access to groundbreaking clinical trials in immunotherapy and targeted therapy, some conducted in collaboration with pharmaceutical companies like Merck and Incyte.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Beverly Hills Cancer Center is a private, academic, community-based cancer treatment center that delivers comprehensive cancer care under one roof. Its core offerings span radiation oncology (SCINTIX biology-guided radiotherapy on the RefleXion X1, Cyberknife radiosurgery, IMRT, IGRT, SBRT, and HDR brachytherapy), medical oncology (chemotherapy, immunotherapy, precision oncology, genetic testing, molecular genetics, and liquid biopsy), advanced diagnostic imaging (MRI, PET/CT, CT, ultrasound, nuclear medicine, bone scans), clinical trials, and integrated support services including a diagnostic reference lab, in-house pharmacy, integrative care, and concierge medical services.

Product overview

Beverly Hills Cancer Center operates as a private, academic community-based cancer center offering comprehensive cancer treatment modalities all under one roof. The center provides a vertically integrated portfolio of diagnostic and treatment services organized around three core pillars: Radiation Oncology (including SCINTIX Biology-Guided Radiotherapy, Cyberknife, external/internal radiation therapy), Medical Oncology (chemotherapy, immunotherapy, genetic testing, precision oncology, liquid biopsy), and Advanced Imaging Services (MRI, PET/CT, CT, nuclear medicine, ultrasound, bone scans, cancer screening). Supporting services include an in-house pharmacy, diagnostic laboratory, clinical trials program, integrative care (acupuncture, nutrition, massage), and concierge medical services. The center also employs AI-powered clinical trial matching through Deep Lens VIPER that integrates with EMR and molecular data feeds from Foundation Medicine, Caris Life Sciences, Tempus, and Guardant Health. Treatment is offered across 23 cancer types including breast, lung, prostate, colon, pancreatic, brain, and skin cancers.

Differentiator

Problem solved

Functional benefit

Products and services

• Radiation Oncology Comprehensive radiation therapy services including external beam radiation therapy, high-dose internal and external radiation therapy, and advanced targeted radiotherapy technologies for cancer patients with tumors throughout the body.
• SCINTIX Biology-Guided Radiotherapy Radiotherapy that uses real-time tumor biology via PET tracer signals to precisely target and track cancer cells during treatment delivery on the RefleXion X1 platform; for cancer patients seeking the world's most advanced radiation therapy.
• Cyberknife Radiosurgery Non-invasive frameless robotic radiation surgery system that delivers high-precision radiation with sub-millimeter accuracy using real-time image guidance and a robotic arm; for patients with benign or malignant tumors.
• Medical Oncology (Chemotherapy) Highly individualized chemotherapy treatments specific to each patient's cancer type and genetic profile, administered in private infusion rooms for cancer patients across all tumor types.
• Immunotherapy Treatments Cancer treatments that harness the body's immune system to fight cancer cells, including checkpoint inhibitors and other targeted immunotherapy approaches; for cancer patients seeking immune-based treatment options.
• Genetic Testing for Cancer Comprehensive genetic testing including germline and somatic testing to identify cancer susceptibility genes and guide personalized treatment decisions; for patients seeking precision oncology treatment planning.
• Molecular Genetics and Total Genome Sequencing Advanced genomic sequencing to analyze the complete genetic makeup of tumors for precision medicine treatment planning; for cancer patients and clinicians seeking molecular-guided therapy decisions.
• Liquid Biopsy Non-invasive blood test that analyzes circulating tumor DNA to detect and monitor cancer without tissue biopsy; for patients requiring cancer detection or treatment monitoring without invasive procedures.
• Hematology Diagnosis and treatment of blood-related cancers and cancer-related blood disorders including leukemia and lymphoma; for patients with hematologic malignancies and related disorders.
• Melanoma Treatment Specialized treatment program for skin cancer including advanced immunotherapy and targeted therapy options; for patients diagnosed with melanoma or other skin cancers.
• Executive Cancer Screening Comprehensive cancer screening program designed for busy executives with personalized risk assessment based on genetic profile and lifestyle; for individuals prioritizing preventive cancer screening.
• MRI Scans GE 1.5T high-resolution digital MRI imaging for detecting, diagnosing, and tracking tumors throughout the body; ACR accredited; for patients and referring physicians.
• PET/CT Scans Combined positron emission tomography and computed tomography for precise cancer localization; ACR accredited; for patients requiring precise staging or restaging of cancer.
• CT Scans State-of-the-art multi-slice CT imaging with high-quality 3D images; ACR accredited; for patients and referring physicians needing diagnostic CT studies.
• Nuclear Medicine Diagnostic imaging using radioactive substances including bone scans, SPECT, and specialized cancer imaging studies; for oncology diagnosis and staging.
• Ultrasound Diagnostic ultrasound imaging for cancer detection including neck, chest, breast, abdomen, and vascular studies; for patients and referring physicians.
• Bone Scans NaF-18 sodium fluoride bone scans for detecting bone metastases with improved anatomic detail; ACR accredited; for patients requiring detection of bone involvement in cancer.
• Cancer Screening Program Customized cancer screening and prevention programs based on individual risk factors, family history, and genetic testing; for individuals seeking preventive cancer screening.
• Complete Health Screening Comprehensive health screening packages including Premiere, Executive, and Total Health packages with imaging and laboratory studies; for executives and individuals seeking comprehensive preventive evaluations.
• Clinical Trials Program Access to groundbreaking clinical trials and research for cancer treatments, including immunotherapy and targeted therapy trials; for cancer patients seeking investigational therapies.
• Concierge Medical Services Premium personalized care including home visits, extended physician appointments, around-the-clock physician access, private chemotherapy rooms, and customized care coordination; for patients seeking high-touch, individualized cancer care.

Quantifiable outcome

• GCR score of 3.85 out of 5 stars
• +3 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability3 records

Feature9 records

Partnerships

Six partnerships are on record, tiered core and minor.

• RefleXion MedicalcoreTechnology or Integration · 10 February 2025First freestanding cancer center to install RefleXion X1 platform with SCINTIX biology-guided radiotherapy. This revolutionary treatment uses real-time tumor biology to precisely target cancer cells. CMS expanded reimbursement for SCINTIX therapy beginning in 2025 for freestanding cancer centers.
• Select Healthcare SolutionsminorImplementation/ SI/ Consulting Partner · 10 February 2025Provider of turn-key medical technology solutions consulted by BHCC to integrate SCINTIX therapy into its comprehensive range of cancer treatment options.
• Deep LenscoreTechnology or Integration · 9 September 2021Strategic collaboration to deploy Deep Lens' AI-based clinical trial matching solution VIPER at Beverly Hills Cancer Center. VIPER integrates with EMR and molecular data feeds from Foundation Medicine, Caris Life Sciences, Tempus, and Guardant Health to automatically identify qualified patients for clinical trials at diagnosis. Partnership aims to accelerate clinical trial enrollment and broaden the center's research program offering.
• Optima Diagnostic ImagingcoreStrategic or Co-development PartnerRelated diagnostic imaging facility sharing the same campus/network, providing PET/CT imaging services. Listed as a partner site on the center's website navigation.
• Merck PharmaceuticalscoreStrategic or Co-development PartnerCollaborated with Merck on clinical trials for immunotherapy for skin cancer, contributing to FDA drug approval that saved many lives for patients who had no other alternative treatment options.
• Incyte CorporationcoreStrategic or Co-development PartnerCollaboration on phase 1b/2 clinical study of INCB039110 combined with nab-paclitaxel and gemcitabine for advanced solid tumors and pancreatic cancer. BHCC served as one of multiple research sites.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• City of Hope: Comprehensive NCI-designated cancer center with multiple Southern California locations including Duarte. Operates the same multi-modality oncology platform (medical oncology, radiation oncology, imaging, clinical trials, concierge services) as BHCC, making it the closest direct geographic and service-line competitor.
• The Oncology Institute of Hope and Innovation: Public community oncology practice operating multi-specialty medical oncology, hematology, and infusion services across multiple US states. Closely comparable to BHCC as a freestanding private/community oncology operator competing on access and pricing rather than academic research depth.
• GenesisCare (21st Century Oncology): Large multi-site private oncology network operating radiation oncology and medical oncology practices across the US and internationally. Closest peer in business model — freestanding private practice oncology with similar technology intensity and reimbursement exposure.

Others

• RefleXion Medical: Manufacturer of the RefleXion X1 biology-guided radiotherapy platform installed at BHCC. Included as an ecosystem/technology partner relevant to understanding BHCC's modality roadmap rather than as a direct competitor; the company depends on RefleXion's commercial trajectory for its SCINTIX differentiation.

Broad incumbents

• MD Anderson Cancer Center: The leading US academic cancer center, providing comprehensive radiation and medical oncology, clinical trials, and imaging. Competes with BHCC primarily for international and second-opinion patients willing to travel for advanced care.
• Memorial Sloan Kettering Cancer Center: Top-ranked US academic cancer center with comprehensive radiation oncology, medical oncology, imaging, and a deep clinical trial pipeline. Competes for international and affluent US patients seeking prestige oncology care, similar to BHCC's positioning.
• Stanford Cancer Institute: NCI-designated academic cancer center at Stanford offering full multi-modality oncology services and clinical research. Comparable to BHCC in advanced technology deployment but with much greater research depth and brand recognition across California.
• Cedars-Sinai Medical Center (Cedars-Sinai Cancer): Large academic hospital system in Los Angeles offering comprehensive cancer care including radiation oncology, medical oncology, and clinical trials. Same LA geography as BHCC with broader inpatient resources, NCI-affiliated research, and competing physician referral networks.
• UCLA Health (Jonsson Comprehensive Cancer Center): NCI-designated comprehensive cancer center at UCLA offering the full suite of radiation and medical oncology services, clinical trials, and imaging. Operates within the same Los Angeles catchment and competes for referrals and international patients with academic research depth BHCC cannot match.
• USC Norris Comprehensive Cancer Center: NCI-designated comprehensive cancer center affiliated with Keck Medicine of USC in Los Angeles, providing radiation oncology, medical oncology, and an extensive clinical trial portfolio in the same LA market as BHCC.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/bhcancercenter
• Facebookfacebook.com/BHCancerCenter

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Beverly Hills Cancer Center